These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 14966076)
1. Massive pulmonary haemorrhage complicating the treatment of acute coronary syndrome. Gill DS; Ng K; Ng KS Heart; 2004 Mar; 90(3):e15. PubMed ID: 14966076 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators N Engl J Med; 1998 May; 338(21):1488-97. PubMed ID: 9599103 [TBL] [Abstract][Full Text] [Related]
3. Tirofiban-induced diffuse alveolar hemorrhage: after primary angioplasty. Guo J; Xu M; Xi Y Tex Heart Inst J; 2012; 39(1):99-103. PubMed ID: 22412240 [TBL] [Abstract][Full Text] [Related]
4. Diffuse alveolar hemorrhage following administration of tirofiban in a patient with acute coronary syndrome: a fatal complication. Yilmaz MB; Akin Y; Biyikoglu SF; Guray U; Korkmaz S Int J Cardiol; 2004 Jan; 93(1):81-2. PubMed ID: 14729442 [No Abstract] [Full Text] [Related]
5. Pulmonary hemorrhage in a patient with acute coronary syndrome. Fernández-Perez GC; Vázquez M; Delgado C; Velasco M; Vázquez-Lima A; Rodríguez-Pérez J AJR Am J Roentgenol; 2007 Sep; 189(3):W135-7. PubMed ID: 17715079 [No Abstract] [Full Text] [Related]
6. Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study). Huynh T; Theroux P; Snapinn S; Wan Y; Am Heart J; 2003 Oct; 146(4):668-73. PubMed ID: 14564321 [TBL] [Abstract][Full Text] [Related]
7. National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United Kingdom. Bakhai A; Flather MD; Collinson JR; Stevens W; Normand C; Alemao E; Itzler R; Ben-Joseph R Int J Cardiol; 2003 Oct; 91(2-3):163-72. PubMed ID: 14559126 [TBL] [Abstract][Full Text] [Related]
19. Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study. Ferguson JJ; Antman EM; Bates ER; Cohen M; Every NR; Harrington RA; Pepine CJ; Theroux P; Am Heart J; 2003 Oct; 146(4):628-34. PubMed ID: 14564315 [TBL] [Abstract][Full Text] [Related]
20. Tirofiban in unstable coronary disease. Liron M N Engl J Med; 1998 Oct; 339(16):1163-5. PubMed ID: 9776651 [No Abstract] [Full Text] [Related] [Next] [New Search]